• Conference Proceeding

CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION [MEETING ABSTRACT PMD86]

Citation

Lynch, J., Chun, D. S., Berse, B., Venne, V., Efimova, O., DuVall, S., ... Kelley, M. J. (2016). CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION [MEETING ABSTRACT PMD86]. Value in Health (ISPOR 21st Annual International Meeting), 19(3), A312.

Abstract

Appropriate use of of the 21-gene RS test decreased use of chemotherapy among low risk patients, and produced significant cost savings and potential improvements in health outcomes. Our study demonstrated opportunities to improve access to testing for eligible Veterans.